CA2138181A1 - Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension - Google Patents

Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension

Info

Publication number
CA2138181A1
CA2138181A1 CA 2138181 CA2138181A CA2138181A1 CA 2138181 A1 CA2138181 A1 CA 2138181A1 CA 2138181 CA2138181 CA 2138181 CA 2138181 A CA2138181 A CA 2138181A CA 2138181 A1 CA2138181 A1 CA 2138181A1
Authority
CA
Canada
Prior art keywords
mmol
composition
compound
formula
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2138181
Other languages
English (en)
French (fr)
Inventor
Verney L. Sallee
Louis Desantis Jr.
Paul W. Zinke
John E. Bishop
Peter G. Klimko
Robert D. Selliah
Thomas R. Dean
Mark R. Hellberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/167,470 external-priority patent/US5721273A/en
Application filed by Individual filed Critical Individual
Publication of CA2138181A1 publication Critical patent/CA2138181A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA 2138181 1993-12-15 1994-12-15 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension Abandoned CA2138181A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16774793A 1993-12-15 1993-12-15
US08/167,747 1993-12-15
US08/167,470 US5721273A (en) 1993-12-15 1993-12-15 Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US08/167,470 1993-12-15
US08/316,672 1994-09-30

Publications (1)

Publication Number Publication Date
CA2138181A1 true CA2138181A1 (en) 1995-06-16

Family

ID=26863209

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2138181 Abandoned CA2138181A1 (en) 1993-12-15 1994-12-15 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension

Country Status (2)

Country Link
JP (1) JP2769294B2 (ja)
CA (1) CA2138181A1 (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196174B (en) * 1984-07-31 1988-10-28 Syntex Inc Process for preparing new prostaglandin derivatives and pharmaceutical compositions containing such active substance
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
JPH0739344B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
ES2118248T3 (es) * 1992-08-31 1998-09-16 Schering Ag Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.

Also Published As

Publication number Publication date
JPH10120572A (ja) 1998-05-12
JP2769294B2 (ja) 1998-06-25

Similar Documents

Publication Publication Date Title
EP0783308B1 (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma
EP1920764B2 (en) Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension
KR100526282B1 (ko) 디플루오로프로스타글란딘유도체및그의용도
ES2225897T3 (es) Analogos de tetrahidrofurano sustituido de prostaglandinas como hipotensores oculares.
US5807892A (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6353000B1 (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
EP0667160A2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
EP0968183A2 (en) 13-thia prostaglandins for use in glaucoma therapy
US5866602A (en) Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US6344581B1 (en) Method of prostaglandin synthesis
CA2138181A1 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
EP0686628A2 (en) Prostaglandin F esters
WO1991013869A1 (en) 15-deoxyprostaglandin derivative
JPH06220011A (ja) １３，１４−ジヒドロ−９−エピ−プロスタグランジン▲ｄ２▼イソプロピルエステル、その製造方法およびそれを含有する薬剤
CA2201294A1 (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma
JPH07309833A (ja) プロスタグランジンｆエステル、その製造方法およびそれを含有する薬剤
JPH06192219A (ja) プロスタグランジンｅ１類縁体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead